Invasive Mold Disease Tied to High ICU and Ventilation Rates
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Half of patients with invasive mold infections require mechanical ventilation, with significantly higher mortality observed in those with recent COVID-19.
Three research teams are developing noninvasive, cost-effective screening tools to improve lung cancer detection rates among smokers and non-smokers.
The American Lung Association’s 2023 "State of Lung Cancer" report reveals improvement in five-year survival rate across the US, including for people of color.
The collaboration will combine flow cytometry and proteomic analysis to help ID specific inflammatory pathways for chronic lung diseases.
Pediatric influenza and Mycoplasma pneumoniae infections returned to pre-pandemic levels after COVID-19 restrictions were lifted.
A proof-of-concept study showed an experimental monoclonal antibody targeting ARDS inflammation increased ventilator-free days and reduced organ failure.
Zidesamtinib (Jideytro) is approved for patients with ROS1-positive non-small cell lung cancer who have previously received targeted therapy.
The USFDA granted 510(k) clearance for the HoneyNaps Somnum V3.0 Ai-based software for polysomnography (PSG) analysis, according to the company.